[HTML][HTML] Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site

A Qaseem, N Usman, JS Jayaraj, RN Janapala… - Cureus, 2019 - ncbi.nlm.nih.gov
Cancer of unknown primary (CUP) is a malignant widespread metastatic disease without an
identifiable primary site after extensive clinical investigation. Recently, a decline is observed …

New Genetic Technologies in Diagnosis and Treatment of Cancer of Unknown Primary

P Krawczyk, J Jassem, K Wojas-Krawczyk… - Cancers, 2022 - mdpi.com
Simple Summary The NGS and other molecular techniques creates huge hopes for effective
CUP patients treatment and to select them for molecularly targeted therapies (agnostic …

The diminishing importance of primary site identification in cancer of unknown primary: a Canadian single-center experience

B Wong, MM Vickers, P Wheatley-Price - Frontiers in Oncology, 2021 - frontiersin.org
Background Cancer of unknown primary (CUP) describes patients with metastatic disease
without an identified primary tumor site. Successful diagnosis and treatment of these patients …

Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review

M Abe, K Watanabe, A Shinozaki-Ushiku, T Ushiku… - BMC cancer, 2019 - Springer
Background Cancers of unknown primary origin (CUPs) are reported to be the 3-4th most
common causes of cancer death. Recent years have seen advances in mutational analysis …

Successful treatment using immunotherapy in combination with chemotherapy for metastatic squamous cell carcinoma of unknown primary origin with bulky …

M Zhang, M Zhao, L Jin, W Shen - Medicine, 2021 - journals.lww.com
Interventions: The patient was treated with carboplatin, albumin-binding paclitaxel, and
immune checkpoint inhibitor (carilizumab). After 6 cycles, the patient was switched to …

Implementation of a metastatic malignancy of unknown primary origin service led by a palliative physician

D Brooks, P Hughes, C Farrington, PA Bath… - Hospital …, 2018 - Taylor & Francis
Background: Cancer of unknown primary is the fourth most common cause of cancer death
in the United Kingdom. National guidance in 2010 recommended the establishment of a …

Estudio de la supervivencia al año de pacientes con metastásis de cáncer de origen desconocido

MR Díaz, DLR Hernández, HH Negrín… - Acta Médica del …, 2021 - medigraphic.com
Introducción: el pronóstico de los pacientes con metastásis de cáncer de origen
desconocido es precario, solo el 25% de los pacientes están vivos al año. Objetivo …

[PDF][PDF] REZUMATUL TEZEI DE DOCTORAT

BA IONUȚ - umfcd.ro
Chirurgia toracică video asistată (CTVA) reprezintă abordul minim invaziv folosit pentru
accesul în torace fără a se utiliza depărtătorul de coaste, imaginea din câmpul operator fiind …

[PDF][PDF] PHD THESIS SUMMARY

BA IONUȚ - umfcd.ro
Video-assisted thoracic surgery (VATS) is the minimally invasive approach used to access
the chest without the use of a rib retractor, the image of the operative field being obtained …

Primeri bilinmeyen maligniteli hastaların değerlendirilmesinde 18F-FDG PET/BT'nin rolü

A Gültekin, T Şengöz - Pamukkale Medical Journal, 2020 - dergipark.org.tr
Amaç: Bu retrospektif çalışmanın amacı, 18F-FDG PET/BT'nin primeri bilinmeyen kanserli
hastalarda primer kanseri saptamadaki etkinliğini araştırmak ve PET/BT sonuçlarını …